JP2023133317A5 - - Google Patents
Info
- Publication number
- JP2023133317A5 JP2023133317A5 JP2023112051A JP2023112051A JP2023133317A5 JP 2023133317 A5 JP2023133317 A5 JP 2023133317A5 JP 2023112051 A JP2023112051 A JP 2023112051A JP 2023112051 A JP2023112051 A JP 2023112051A JP 2023133317 A5 JP2023133317 A5 JP 2023133317A5
- Authority
- JP
- Japan
- Prior art keywords
- invention described
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762579716P | 2017-10-31 | 2017-10-31 | |
| US62/579,716 | 2017-10-31 | ||
| PCT/US2018/058134 WO2019089534A1 (en) | 2017-10-31 | 2018-10-30 | C5aR INHIBITOR REDUCTION OF URINARY sCD163 |
| JP2020523705A JP7789483B2 (ja) | 2017-10-31 | 2018-10-30 | Ｃ５ａＲ阻害剤による尿中ｓＣＤ１６３の減少 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020523705A Division JP7789483B2 (ja) | 2017-10-31 | 2018-10-30 | Ｃ５ａＲ阻害剤による尿中ｓＣＤ１６３の減少 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023133317A JP2023133317A (ja) | 2023-09-22 |
| JP2023133317A5 true JP2023133317A5 (https=) | 2026-03-09 |
Family
ID=66326509
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020523705A Active JP7789483B2 (ja) | 2017-10-31 | 2018-10-30 | Ｃ５ａＲ阻害剤による尿中ｓＣＤ１６３の減少 |
| JP2023112051A Pending JP2023133317A (ja) | 2017-10-31 | 2023-07-07 | Ｃ５ａＲ阻害剤による尿中ｓＣＤ１６３の減少 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020523705A Active JP7789483B2 (ja) | 2017-10-31 | 2018-10-30 | Ｃ５ａＲ阻害剤による尿中ｓＣＤ１６３の減少 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US20190134020A1 (https=) |
| EP (2) | EP4671767A3 (https=) |
| JP (2) | JP7789483B2 (https=) |
| KR (1) | KR20200109297A (https=) |
| CN (1) | CN111670185A (https=) |
| AR (1) | AR113815A1 (https=) |
| AU (2) | AU2018359237A1 (https=) |
| CA (1) | CA3078732A1 (https=) |
| WO (1) | WO2019089534A1 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11191756B2 (en) | 2018-06-07 | 2021-12-07 | Chemocentryx, Inc. | Dosing and effect of C5a antagonist with ANCA-associated vasculitis |
| WO2020112961A1 (en) | 2018-11-30 | 2020-06-04 | Chemocentryx, Inc. | Capsule formulations |
| CN114867473A (zh) * | 2019-11-08 | 2022-08-05 | 凯莫森特里克斯股份有限公司 | 补体成分c5a受体的盐形式 |
| US11603356B2 (en) | 2019-11-08 | 2023-03-14 | Chemocentryx, Inc. | Amorphous form of a complement component C5a receptor |
| TWI869528B (zh) | 2020-01-13 | 2025-01-11 | 美商威特拉公司 | C5ar1抗體分子及其用途 |
| CN116529241A (zh) * | 2020-10-28 | 2023-08-01 | 坎莫森特里克斯公司 | 治疗化脓性汗腺炎的方法 |
| JP7839157B2 (ja) * | 2020-10-28 | 2026-04-01 | ケモセントリックス， インコーポレイテッド | 化膿性汗腺炎を処置する方法 |
| WO2022140258A1 (en) * | 2020-12-21 | 2022-06-30 | Chemocentryx, Inc. | Treatment of c3 glomerulopathy using a c5a inhibitor |
| CA3173944A1 (en) | 2021-01-13 | 2022-07-21 | Visterra, Inc. | Humanized complement 5a receptor 1 antibodies and methods of use thereof |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1268002A (en) | 1917-09-12 | 1918-05-28 | William M Goodwin | Measuring instrument. |
| US4166452A (en) | 1976-05-03 | 1979-09-04 | Generales Constantine D J Jr | Apparatus for testing human responses to stimuli |
| US4256108A (en) | 1977-04-07 | 1981-03-17 | Alza Corporation | Microporous-semipermeable laminated osmotic system |
| US4265874A (en) | 1980-04-25 | 1981-05-05 | Alza Corporation | Method of delivering drug with aid of effervescent activity generated in environment of use |
| RS54998B1 (sr) | 2008-12-22 | 2016-11-30 | Chemocentryx Inc | Antagonisti c5ar |
| US20110275639A1 (en) * | 2008-12-22 | 2011-11-10 | Chemocentryx, Inc. | C5aR ANTAGONISTS |
| RS56332B1 (sr) | 2010-06-24 | 2017-12-29 | Chemocentryx Inc | Antagonisti c5ar |
| DK3200791T3 (da) | 2014-09-29 | 2020-05-25 | Chemocentryx Inc | Fremgangsmåder og mellemprodukter i fremstilling af C5AR- antagonister |
| WO2016166357A2 (en) * | 2015-04-17 | 2016-10-20 | The Provost, Fellows, Foundation Scholars, & The Other Members Of Board, Of The College Of The Holy & Undiv. Trinity Of Queen Elizabeth, Near Dublin | Method and assay for diagnosing rapidly progressive glomerulonephritis in a subject |
| EP3439658B1 (en) * | 2016-04-04 | 2021-11-24 | ChemoCentryx, Inc. | Soluble c5ar antagonists |
-
2018
- 2018-10-30 CA CA3078732A patent/CA3078732A1/en active Pending
- 2018-10-30 US US16/174,658 patent/US20190134020A1/en not_active Abandoned
- 2018-10-30 AU AU2018359237A patent/AU2018359237A1/en not_active Abandoned
- 2018-10-30 CN CN201880070265.5A patent/CN111670185A/zh active Pending
- 2018-10-30 WO PCT/US2018/058134 patent/WO2019089534A1/en not_active Ceased
- 2018-10-30 EP EP25198900.0A patent/EP4671767A3/en active Pending
- 2018-10-30 JP JP2020523705A patent/JP7789483B2/ja active Active
- 2018-10-30 KR KR1020207015095A patent/KR20200109297A/ko not_active Ceased
- 2018-10-30 EP EP18873880.1A patent/EP3704110A4/en not_active Ceased
- 2018-10-31 AR ARP180103168A patent/AR113815A1/es unknown
-
2022
- 2022-07-29 US US17/815,992 patent/US20230105869A1/en active Pending
-
2023
- 2023-07-07 JP JP2023112051A patent/JP2023133317A/ja active Pending
-
2024
- 2024-04-19 AU AU2024202593A patent/AU2024202593A1/en active Pending